Trudel M, Garel M C, Saadane N, Rouyer-Fessard P, Vidaud D, Costantini F, Beuzard Y
Department of Genetics and Development, Columbia University, New York, NY 10032.
Nouv Rev Fr Hematol (1978). 1990;32(6):407-8.
Very recently a high expression of human hemoglobin S, which causes sickle cell disease, has been obtained in transgenic mice. We have constructed a modified beta S gene, beta SAD which carries two additional mutations in order to induce polymerization of transgenic hemoglobin when diluted by endogenous mouse Hb. The transgenic SAD mice are not anemic but exhibit a low percentage of irreversible sickle cells. Sickling is induced by deoxygenation of erythrocytes in vitro. In addition, the anemia of neonates and the low incidence of SAD animals in the progeny suggest a deleterious effect of SAD Hb during development. Finally, hypoxia induces a high mortality in SAD adults suggesting the induction of vaso-occlusive events.
最近,在转基因小鼠中已实现了导致镰状细胞病的人类血红蛋白S的高表达。我们构建了一个经过修饰的βS基因,即βSAD,它携带另外两个突变,以便在被内源性小鼠血红蛋白稀释时诱导转基因血红蛋白聚合。转基因SAD小鼠没有贫血,但表现出低比例的不可逆镰状细胞。镰状化可通过体外红细胞脱氧诱导产生。此外,新生儿贫血以及后代中SAD动物的低发生率表明SAD血红蛋白在发育过程中具有有害作用。最后,缺氧会导致SAD成年小鼠的高死亡率,提示发生了血管阻塞事件。